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A B S T R A C T
Purpose: Minocycline is known as a chemical with neuroprotective, anti-inﬂammatory, and antimicro-
bial properties. In this study, the effects of minocycline on seizures induced by amygdala kindling in rats
were studied.
Methods: Kindled Wistar rats were injected intraperitoneally with saline and, on the following day, with
minocycline (50, 25, and 12.5 mg/kg for the three groups (1–3), respectively). The animals in groups 1–3
had similar protocols. Groups 4 and 5 were given for the rotarod test and received 25 or 50 mg/kg
minocycline, respectively, without any kindling stimulation. The animals in groups 6 and 7 (seven each)
received 25 mg/kg minocycline or saline, respectively. All the injections were carried out 1 h before
kindling stimulation. Seizure parameters, including after discharge duration (ADD), stage 4 latency (S4L),
stage 5 duration (S5D), and seizure duration (SD), were recorded and compared with those of the saline
groups.
Results: Minocycline (50 mg/kg) signiﬁcantly reduced ADD, 1/S4L, S5D, and SD (P < 0.001, P < 0.05,
P < 0.001, and P < 0.001, respectively) in group 1. While the administration of 25 mg/kg of minocycline
decreased the ADD and S5D (P < 0.05), in group 2. The injection of 12.5 mg/kg resulted in decreased S5D
(P < 0.001) in group 3. The daily injection of minocycline (25 mg/kg) signiﬁcantly decreased ADD, S5D,
and SD (P < 0.001) in group 6.
Conclusion: The obtained results revealed that minocycline has anticonvulsant effect on seizures
induced by amygdala kindling. Thus, it may be useful for epilepsy treatment.
 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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After stroke and Alzheimer’s disease, epilepsy is the most
common neurological disorder.1 Epidemiological studies show
that more than one percent of people in the world suffer from
epilepsy.2 Kindling animal models of epilepsy are broadly used to
understand the neurobiology of this disorder and to discover new
and effective treatments.3 Kindling refers to the gradual develop-
ment of electrographic and behavioral seizure in response to
repeated applications of brief, intermittent, and low-intensity
trains of electrical stimulation.4 By means of this laboratory model,
one can determine the effects of various drugs and chemicals on
seizures created in a speciﬁc area.
Although extensive research has been carried out on epilepsy
and seizures, its exact etiology is still not known.5 There are some* Corresponding author. Tel.: +98 571 4446070; fax: +98 571 4415648.
E-mail address: mohamad1353@gmail.com (M. Mohammad-Zadeh).
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http://dx.doi.org/10.1016/j.seizure.2013.05.005reports on the development of inﬂammatory reaction during
epilepsy attacks, including increased release of cytokines, chemo-
kines, and prostaglandins in the brains of rodents.6–8 Therefore,
anti-inﬂammatory agents such as minocycline could probably be
an appropriate choice to decrease epileptic attacks. The anticon-
vulsant effects of tetracycline-class antibiotics minocycline,
doxycycline, and tetracycline were demonstrated in mice using
6-Hz (minimal clonic seizure) test.9 Minocycline inhibits seizure-
induced inﬂammation and also abolishes the increased suscepti-
bility to the second seizure in kainic acid induced status
epilepticus.10 Seizure frequency reduction during minocycline
therapy has been reported in clinical studies.11
Minocycline is an antibiotic of tetracycline family, having both
antimicrobial properties and anti-inﬂammatory effects. It can pass
the blood-brain barrier, and affect the activities of brain cells.12,13
The systemic injection of minocycline reduces both the activity of
microglia and the production of inﬂammatory cytokines in the
central nervous system.14–16 It also protects neurons against
traumatic brain damages.17,18 Thus, because of its anti-inﬂammatoryvier Ltd. All rights reserved.
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seizures. Therefore, in the present study, an attempt was made to
examine the effects of minocycline on amygdala kindling-induced
seizures.
2. Materials and methods
2.1. Animals
Forty-ﬁve adult male Wistar rats (8–9 weeks old) were obtained
from Razi Institute of Iran. The animals were kept in a colony room
with a constant temperature on 12:12 light:dark schedule. The
animals were individually housed in plastic cages with woodchip
bedding and permitted free access to food and water. Procedures
involving animals and their care were conducted in accordance
with the ‘‘Guide to the Care and Use of Experimental Animals.’’19
All of the experiments were done during the same time of the day
(8:00 a.m. to 2:00 p.m.) in the morning to avoid the bias of
circadian rhythms.20,21
2.2. Surgical and kindling procedure
For stereotaxic surgery, the animals were anesthetized by
ketamine (100 mg/kg, i.p.). The rats were implanted with bipolar
stimulating and monopolar recording electrodes (twisted into a
tripolar conﬁguration) terminating in the basolateral amygdala
(coordinates: A, 2.5 mm; L, 4.8 mm and 7.5 mm below dura) of
the right hemisphere.22 The electrodes (stainless steel, Teﬂon-
coated, 127 mm in diameter, AM-Systems, USA) were insulated
except at the tips. Two other electrodes were connected to skull
screws, placed above the left cortical surface as reference and
differential electrodes. One week after surgery, after discharge
(AD) threshold was determined in basolateral amygdala by a 2 s,
60 Hz monophasic square wave stimulus of 1 ms per wave (by
Electromodule D3111, ScienceBeam Institute, Tehran, Iran). The
stimulations were initially delivered at 10 mA and then at 5-min
intervals, increasing stimulus intensity in increments of 10 mA
until at least 5 s of ADs were recorded as described previously.23
Evoked responses were ampliﬁed, ﬁltered, and digitized (at
10 KHz) using a PC-based data acquisition system and recording
software (Electromodule D3111 and NeuroTrace provided by
Science Beam Institute, Tehran, Iran) and were continuously
monitored and stored on computer hard drive.
The duration of epileptiform after discharges and the behavioral
progression of kindling (stages 1–5 according to Racine’s scale)
were monitored.3 Brieﬂy, stage 1 involved chewing movements;
stage 2, included head nodding; stage 3, unilateral forelimb clonus;
stage 4, bilateral forelimb clonus; and stage 5,rearing on the
hindlimbs and loss of postural control. Then, the animals were
stimulated twice daily (minimum interval 6 h) at the AD threshold
intensity until ﬁve consecutive stage 5 seizures3 were elicited. The
recorded parameters were: AD duration (ADD), the latency to the
onset of bilateral forelimb clonus (S4L), the duration of stage 5
(S5D), and the seizure stage (SS). Seizure parameters according to
Racine scales3 were as follows: S4L was measured from the start of
the stimulation until the beginning of stage 4 seizure. The duration
of stage 5 (S5D) was measured from the start of stage 5 until the
end of this stage. Seizure duration was measured from beginning
until the end of seizure behavior. ADD was measured from the start
of the stimulation until the end of ADs.
2.3. Drug administration
Minocycline (Sigma, St. Louis, MO) was dissolved in normal
saline. The drug was injected intraperitoneally 60 min before
kindling stimulation.2.4. Experimental design
The animals were classiﬁed into seven groups: Groups 1–3
(seven each) were stimulated twice daily (with a minimum
interval of 6 h) at the AD threshold intensity until ﬁve consecutive
stage 5 seizures were elicited. These animals were considered fully
kindled. Fully kindled rats were subjected to saline (1 ml/kg)
injection and different minocycline doses (50, 25, and 12.5 mg/kg
in groups 1–3, respectively) intraperitoneally on the following day.
The animals in groups 4 (n = 5) (receiving 25 mg/kg minocy-
cline) and 5 (n = 5) (receiving 50 mg/kg minocycline) which did not
receive any kindling stimulation, were used for the rotarod test.
After the rotarod test (see Section 2.5), a dosage of 25 mg/kg was
selected for the following experiments. The animals in groups 6
(n = 7) received 25 mg/kg minocycline, and those in group 7 (n = 7)
received saline, 1 h before daily kindling stimulation. Kindling
stimulation continued twice daily (with a minimum interval of 6 h)
at the AD threshold intensity until stage 5 seizures were elicited,
whereas minocycline or saline injection was performed once daily
(1 h before the ﬁrst kindling stimulation).
2.5. Rotarod
In view of the large number of daily injections in group 6, a
rotarod test was used to determine the suitable dose of
minocycline. It was considered likely that minocycline in high
doses could have non-seizure behavioral effects in addition to its
anticonvulsant effects. If non-seizure behavioral effects were not
seen in the doses used, the highest dose administered to groups 1–
3 was selected for group 6. In the rotarod assay, the animals were
placed on a rotating rod that accelerated from 5 to 20 rpm over
30 s, and the latency to fall was manually recorded. Each animal
had two 5-min training sessions. The following day, all animals
were re-tested for their ability to complete a 3-min trial prior to
minocycline administration. Two groups of the animals were
injected with 25 and 50 mg/kg minocycline and tested on the
Rotarod at 20-min intervals until two consecutive 3-min trials
were completed. The length of time for which the animals are able
to stay on the rotating rod is a measure of their coordination.24
2.6. Histology
All the animals were sacriﬁced at the end of the procedure.
Their brains were removed, sectioned, and examined under
microscope for electrode positions and the presence of any tissue
damage such as lesions. In case of any abnormality, the data from
that particular animal were excluded for the ﬁnal analysis.
2.7. Statistical analysis
The results are expressed as the means  S.E.M., accompanied by
the number of observations. The differences between the two
dependent groups (Groups 1–5) were analyzed using paired Student’s
t-test. A repeated measures ANOVA was used to determine changes in
cumulative ADD, (the sum of after discharge durations recorded after
10 daily stimulations), cumulative S5D, and cumulative SD (Groups 6–
7). A P value less than 0.05 was considered to represent a signiﬁcant
difference.
3. Results
There was no signiﬁcant difference in after discharge threshold
between the different groups on the ﬁrst day of stimulation. That
is, all kindled rats responded with stable stage 5 seizures in either a
non-infusion condition or after normal saline infusion. Histological
assessment indicated that the electrodes were positioned in the
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incorrect position of electrodes or disruption of their electrophys-
iological responses during freely moving records.
3.1. Effects of intraperitoneal injection of minocycline on amygdala-
kindled seizures
In the ﬁrst part of the experiments, the animals (groups 1–3)
were stimulated 1 and 24 h after minocycline injection (50, 25, and
12.5 mg/kg for groups 1–3, respectively) and then the seizure
parameters were measured.
3.1.1. Effects of minocycline on amygdala-kindled seizures after 1 h
One hour after minocycline injection (50 mg/kg), the values of
ADD, 1/S4L, S5D, and SD signiﬁcantly reduced compared to those of
saline-treated animals (Fig. 1A). The injection of 25 mg/kg of the
drug caused a signiﬁcant reduction in the values of ADD and S5D
(P < 0.05) (Fig. 1B). One hour after the injection of 12.5 mg/kg
minocycline, S5D was signiﬁcantly reduced compared to those of
saline treatment (Fig. 1C).
3.1.2. Effects of minocycline on amygdala-kindled seizures after 24 h
S5D was signiﬁcantly reduced 24 h after injecting 12.5, 25, and
50 mg/kg of minocycline (P < 0.01, P < 0.01, and P < 0.001,Fig. 1. The effect of different doses of minocycline (50 mg/kg (A), 25 mg/kg (B), and
12.5 mg/kg (C)) on amygdala after discharge duration (ADD), inverse of latency to
onset of stage 4 (1/S4L), stage 5 duration (S5D), and seizure duration (SD) at two
time points (1 and 24 h represented by black and gray, respectively) after injection
of the drug (i.p.) in amygdala-kindled rats (n = 6). Values are mean  S.E.M.,
*P < 0.05, **P < 0.01 and ***P < 0.001 when compared to saline injection by two-tailed
paired t-test.respectively), but S4L and SD did not change signiﬁcantly
compared to those of groups with saline treatment (Fig. 1).
Since 3 doses of minocycline were injected into all three groups
of animals and the convulsive parameters were recorded twice for
every injected dose (1 h and 24 h after injection), the dose-
dependency and time-dependency features of the drug effect were
studied. As for the ADD parameter, a repeated measures ANOVA on
the obtained data revealed no signiﬁcant effect of dose [F(2,15) = 0.8,
P = 0.4], but a signiﬁcant effect for time [F(2,30) = 1041, P < 0.001] or
interaction of time and dose [F(4,30) = 965, P < 0.001].
Repeated measures ANOVA for S4L showed that the drug effect
is merely time-dependent [F(2,30) = 3.8, P < 0.05]. The same test for
S5D showed that this effect is dose-dependent [F(2,15) = 6.9,
P < 0.05], time-dependent [F(2,30) = 74.4, P < 0.001], and also
dependent on the interaction of time and dose [F(4,30) = 5,
P < 0.01]. The statistical test for the SD quantity showed that this
effect is not dose-dependent [F(2,15) = 1.4, P < 0.02], but is time-
dependent [F(2,30) = 80.5, P < 0.001] and time  dose dependent
[F(4,30) = 84.2, P < 0.001].
3.2. Effect of minocycline on amygdala kindling acquisition
As observed in Section 3.1, minocycline mostly affected the
convulsive parameters in a dose of 50 mg/kg. In addition, as stated
in the previous section, the 50 mg/kg dose of the drug was injected
to the kindled rats only once. The selected dose to study the
kindling acquisition must have an anticonvulsant effect on the one
hand, and should not affect the animal’s non-convulsive behavior
on the other hand. Therefore, the rotarod behavioral test was used
to select the appropriate dose (between 50, 25, and 12.5 mg/kg
doses).
For this purpose, 25 and 50 mg/kg doses of minocycline were
injected intraperitoneally into the animals in groups 4 and 5. One
hour later, rats were placed in rotarod apparatus to record their
balance duration. The results revealed that injecting the 50 mg/kg
dose of minocycline (group 4) signiﬁcantly reduced the balance
duration compared to those of the saline group (P < 0.01).
However, injecting the 25 mg/kg dose of the drug did not affect
the animal behavior signiﬁcantly in group 5 (Table 1). The Animals
in groups 4 and 5 were injected with saline on the day before.
Therefore, the data for each group were compared with the results
of saline injection on the previous day. Finally, the dose of 25 mg/
kg was selected to study the effects of minocycline on kindling
acquisition.
Given that the experimental groups of this section (groups 6
and 7) received daily minocycline injections and electrical
stimulations for ten days, the convulsive parameters were
analyzed statistically and cumulatively. The cumulative ADD
(cADD) was signiﬁcantly reduced in the animals receiving daily
injections of the 25 mg/kg dose of minocycline (group 6) compared
to the group receiving saline (group 7) [F(18,216) = 3.5; P < 0.001]
(Fig. 2). The cumulative S5D (cS5D) was also signiﬁcantly reduced
in the animals of group 6 (recipients of minocycline) compared to
the group 7 (P < 0.001) (Fig. 3).
A repeated measures ANOVA on the obtained data showed that
cSD was signiﬁcantly reduced in the animals receiving the 25 mg/
kg dose of minocycline compared to the saline group
[F(19,228) = 3.8; P < 0.001)] (Fig. 4).
3.2.1. Effect of minocycline on amygdala kindling rate
At the ﬁrst day of the experiments, there was no signiﬁcant
difference between after discharge threshold of kindled + saline
(50  4.6 mA) and kindled + minocycline (48.5  4 mA) groups. Thus,
there was no difference in seizure susceptibility of different groups at
the beginning of experiments. The application of minocycline (25 mg/
kg) resulted in a signiﬁcant retardation of kindling acquisition.
Table 1
Effect of minocycline injection (i.p.) on duration of equilibrium preservation.
Minocycline (50 mg/kg) Minocycline (25 mg/kg)
Saline Minocycline Saline Minocycline
Duration of equilibrium preservation 487.5  7.3 184  26.4** 525.6  17.4 485.2  7.5
Values are mean  S.E.M.
** P < 0.01 compared to saline injection (n = 5).
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stimulations required to reach the fully kindled state (stage 5) or
other seizure stages was signiﬁcantly increased in kindled + minocy-
cline group compared with kindled + saline group (P < 0.001) (Fig. 5).
4. Discussion
The results of the present study showed that minocycline had
anticonvulsant effect in fully kindled rats. Moreover, the injection
of minocycline (25 mg/kg) for 10 days had antiepileptogenic effect
during kindling acquisition and retarded kindling acquisition.
One of the most important characteristics of the temporal lobe
epilepsy is the increase of glial production.25,26 It has been shown
that the level of cytokines, such as IL-1b, TNF-a, and IL-6, in the
brains of mice are rapidly (30 min) increased at mRNA and
protein levels after the induction of seizures (chemically or
electrically), while they are expressed at very low levels in normal
brain, and declined to basal levels within 48–72 h from the seizure
onset.7 Moreover, it has been shown that 2 h following the last
generalized convulsive seizure triggered from kindled amygdala, a
signiﬁcant up-regulation of IL-1b,IL-1RI, TNF-a, and TGF-b1
mRNAs occurs in parietal and piriform cortices, amygdala, andFig. 2. The effect of daily injection of minocycline (25 mg/kg) on cumulative ADD
during amygdala kindling acquisition. Minocycline decreased cumulative ADD
relative to saline group. Values are mean  S.E.M. ***P < 0.001 (n = 7).
Fig. 3. The effect of daily injection of minocycline (25 mg/kg) on cumulative S5D
during amygdala kindling acquisition. Minocycline decreased cumulative S5D
relative to saline group. Values are mean  S.E.M. and ***P < 0.001 (n = 7).hippocampus.26 On the other hand, the excessive release of the
inﬂammatory cytokines leads to the neurotoxic effects of neurons
and induces seizures.27,28 Many reports indicate that the
inﬂammatory cytokines induce seizures.8,29,30
It has been shown that in mice, in which exaggerated
neuroinﬂammation was elicited by lipopolysaccharides, minocy-
cline pretreatment was effective in reducing mRNA levels of IL-1b
and TLR2. Also, minocycline decreased mRNA expression of
inﬂammatory genes including IL-6, IL-1b, MHCII, and TLR2 in in
vitro study.31 Therefore, minocycline might be effective in the
reduction of the epileptic seizure either by reducing the production
of cytokines or by blocking the effects on the cell surface. The
anticonvulsant effects observed in this study can be attributed to
the anti-inﬂammatory effects of minocycline.
Pre-treatment with minocycline 1 h before stimulation in
kindling acquisition group reduced the seizure parameters
markedly. Based on 2–3 h half-life of minocycline in rodents, weFig. 5. The effect of minocycline injection on the number of stimulations needed to
achieve different seizure stages. There is a signiﬁcant increase in the number of
stimulations to seizure stage 3 and seizure stage 5. Values are mean  S.E.M. (n = 6
in kindled + saline group and n = 7 in kindled + minocycline group). *P < 0.05 and
**P < 0.01 when compared to kindled + saline group.
Fig. 4. The effect of daily injection of minocycline (25 mg/kg) on cumulative SD
during amygdala kindling acquisition. Minocycline decrease cumulative SD relative
to saline group. Values are mean  S.E.M. ***P < 0.001 (n = 7).
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results are consistent with a recent study showing anticonvulsant
effects of minocycline in 6 Hz test models of epilepsy.9 In addition,
another report has shown marked reduction in seizure frequency
during minocycline therapy in some patients.11
The intraperitoneal injection of minocycline reduced the
electrophysiological parameter of ADD signiﬁcantly. ADD indicates
the activity of the temporal circuits in the registration area, which
depends on the nature of neurons and their circuits. It is also
presumed that minocycline reduces this parameter during the
kindling process by inhibiting the neuronal circuits of the
amygdala area. In this study, it was observed that minocycline
signiﬁcantly reduced the duration of seizures.
In our study, minocycline delayed the kindling procedure and
increased the number of stimulations required to reach different
kindled seizure stages observed on acquisition of both focal (stage
3) and generalized (stage 4 and 5) seizures. In other words, it seems
that minocycline prolongs the generalization stage of seizures in
kindling, since S4L is the generalization rate index of the seizure
attacks and is relevant to the involvement of the brain stem circuits
leading to the seizure generalization. In addition, it was observed
that minocycline reduced the S5D signiﬁcantly, indicating that the
duration of tonic–clonic convulsions was reduced after minocy-
cline. In accordance with our results, it has been shown that
minocycline treatment in mice suppressed the increased suscep-
tibility to the second seizure later in life.10 Yet it is not certainly
clear whether epilepsy and induced seizures create the inﬂamma-
tory agents, or the inﬂammatory agents themselves create
epilepsy.32
5. Conclusion
According to the present study and other studies,9–11 it is
postulated that minocycline can be effective in reducing epileptic
seizures, probably through suppression of inﬂammation. Apart
from a few case reports, there is no clear evidence of anticonvul-
sant effect of minocycline in human. Based on the results of this
study, more studies seem necessary to investigate the possible
beneﬁts of minocycline in epileptic patients receiving minocycline
as treatment for infections.
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